CIK: 0001372218 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $906,821 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRCT | PROCEPT BIOROBOTICS CORP | 11,222,662 | $428,145 | 47.2% | $38.38 | 0.0% | COM | 74276L105 |
| — | REATA PHARMACEUTICALS INC | 2,896,901 | $291,457 | 32.1% | $31.64 | — | CL A | 75615P103 |
| — | INSTIL BIO INC | 8,478,790 | $151,558 | 16.7% | $25.08 | — | COM | 45783C101 |
| — | APOLLO ENDOSURGERY INC | 3,194,871 | $28,946 | 3.2% | $3.34 | — | COM | 03767D108 |
| QQQ | INVESCO QQQ TR | 18,758 | $6,715 | 0.7% | $301.60 | — | UNIT SER 1 | 46090E103 |